House Rx
PrivateLast Round
Series B
Nov 12, 2025
Total Funding Raised
$85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
House Rx operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series B round in November 2025.
House Rx is a healthcare technology and services company that partners with specialty clinics to provide medically integrated pharmacy care for patients.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Medical AI, Pharma Supply Chain, Healthcare Analytics, EHR & EMR
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
House Rx Comparables
Compare House Rx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Health Bridge | 83% | |
| Elevate Health Technologies | 83% | |
| Forus | 76% |
For institutional investors. Book with your work email.
House Rx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 12, 2025 | ||||
| Series A | Mar 14, 2022 | ||||
| Seed | Sep 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
House Rx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Town Hall Ventures | Series B |
| Maverick Ventures | Seed |
| New Enterprise Associates | Series B |
| Khosla Ventures | Seed |
| Character Capital | Series A |
| First Round Capital | Series B, Series A, Seed |
| LRVHealth | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 6, 2026
Grew 15% QoQ, from 259 to 298 employees.
- Nov 12, 2025
$55M Series B round completed.
For institutional investors. Book with your work email.
House Rx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about House Rx's valuation, stock price, and market status.
Is House Rx a public or private company?
House Rx is a private company.
What is the current stock price of House Rx?
House Rx is a private company, so its shares have no public market price. Caplight tracks House Rx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is House Rx worth (valuation)?
Valuation information for House Rx is not publicly available.
Can I buy House Rx stock?
House Rx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was House Rx's last funding round?
House Rx's most recent funding round was Series B on November 12, 2025.
Who are the main investors in House Rx?
Key investors in House Rx include Town Hall Ventures, New Enterprise Associates, First Round Capital, Bessemer Venture Partners.
Will House Rx IPO soon?
No public IPO plans have been announced for House Rx.
How can I track House Rx secondary market activity?
Caplight tracks bids, offers, and trades in House Rx's shares on secondary markets.